BioForce Financial Statements From 2010 to 2025
| BFNH Stock | USD 0.34 0.25 42.37% |
Check BioForce Nanosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioForce Nanosciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . BioForce financial statements analysis is a perfect complement when working with BioForce Nanosciences Valuation or Volatility modules.
BioForce |
BioForce Nanosciences Holdings Company Shares Owned By Insiders Analysis
BioForce Nanosciences' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current BioForce Nanosciences Shares Owned By Insiders | 82.29 % |
Most of BioForce Nanosciences' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioForce Nanosciences Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 82% of BioForce Nanosciences Holdings are shares owned by insiders. This is much higher than that of the Consumer Defensive sector and 216.01% higher than that of the Packaged Foods industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
BioForce Nanosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioForce Nanosciences's current stock value. Our valuation model uses many indicators to compare BioForce Nanosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioForce Nanosciences competition to find correlations between indicators driving BioForce Nanosciences's intrinsic value. More Info.BioForce Nanosciences Holdings is rated below average in return on asset category among its peers. It is the top company in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value BioForce Nanosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioForce Nanosciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About BioForce Nanosciences Financial Statements
Investors use fundamental indicators, such as BioForce Nanosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although BioForce Nanosciences' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, and mass merchandisers under the BioForce Eclipse brand, as well as through online and telemarketing. BIOFORCE NANOSCIENCES operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 2 people.
Currently Active Assets on Macroaxis
| NVDA | NVIDIA | |
| CRESY | Cresud SACIF y | |
| GOOG | Alphabet Inc Class C | |
| FMC | FMC Corporation | |
| XYF | X Financial Class |
Other Information on Investing in BioForce Pink Sheet
BioForce Nanosciences financial ratios help investors to determine whether BioForce Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioForce with respect to the benefits of owning BioForce Nanosciences security.